Literature DB >> 236938

Mechanism of action of narcotics in the production of menstrual dysfunction in women.

F J Santen, J Sofsky, N Bilic, R Lippert.   

Abstract

The ability of morphine to block ovulation in animals prompted investigation of the frequency and mechanisms of menstrual abnormalities in women addicted to narcotic analgesics. Menstrual histories obtained from 76 former heroin addicts receiving daily methadone maintenance revealed that more than one-half of these women had experienced menstrual abnormalities while taking heroin or methadone. In order to determine the specific physiologic effects of narcotic analgesics on reproductive function, detailed endocrinologic studies were carried out in seven of these patients who complained of amenorrhea or irregular menses while receiving methadone. Four of the seven women manifested abnormalities of the control of gonadotropin secretion. Three of these four failed to exhibit cyclic gonadotropin release, as evidenced by an absence of increased levels of follicular phase follicle-stimulating hormone, midcycle gonadotropin peaks or luteal phase progesterone increments. In the fourth patient a prolonged follicular phase (30 days) of the menstrual cycle was detected. One of these four patients also had low basal gonadotropin levels and failed to exhibit luteinizing hormone increments greater than control levels in response to ethinyl estradiol (positive feedback). The remaining three women exhibited normal patterns of gonadotropin secretion during the observation period. In these women, menstrual bleeding occurred in response to withdrawal from luteal phase (10 to 20 ng/ml) progesterone levels and to exogenous ethinyl estradiol, suggesting normal uterine responsivity to progesterone and estrogen. Although not documented, it is likely that oligo-ovulation was the cause of the irregular menses in these three patients. Amenorrhea is commonly associated with methadone ingestion or heroin addiction and appears to be related to an alteration of the hypothalamic mechanisms controlling gonadotropin secretion. Tolerance to these effects of methadone may develop after chronic ingestion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 236938

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Endorphins and exercise.

Authors:  V J Harber; J R Sutton
Journal:  Sports Med       Date:  1984 Mar-Apr       Impact factor: 11.136

2.  Gonadal and Adrenal Abnormalities in Drug Users: Cause or Consequence of Drug Use Behavior and Poor Health Outcomes.

Authors:  Todd T Brown; Amy B Wisniewski; Adrian S Dobs
Journal:  Am J Infect Dis       Date:  2006

Review 3.  Long-term Opioids Linked to Hypogonadism and the Role of Testosterone Supplementation Therapy.

Authors:  Suganya Marudhai; Mauli Patel; Sharathshiva Valaiyaduppu Subas; Mohammad R Ghani; Vishal Busa; Ahmed Dardeir; Ivan Cancarevic
Journal:  Cureus       Date:  2020-10-05

4.  Sex differences in daily life stress and craving in opioid-dependent patients.

Authors:  Landhing M Moran; William J Kowalczyk; Karran A Phillips; Massoud Vahabzadeh; Jia-Ling Lin; Mustapha Mezghanni; David H Epstein; Kenzie L Preston
Journal:  Am J Drug Alcohol Abuse       Date:  2018-04-11       Impact factor: 3.829

5.  Contraceptive Knowledge among Females and Males Receiving Medication Treatment for Opioid Use Disorder Compared to Those Seeking Primary Care.

Authors:  Heidi S Melbostad; Gary J Badger; Catalina N Rey; Lauren K MacAfee; Anne K Dougherty; Stacey C Sigmon; Sarah H Heil
Journal:  Subst Use Misuse       Date:  2020-10-05       Impact factor: 2.164

Review 6.  Menstrual dysfunction in pathophysiologic states.

Authors:  L S Neinstein
Journal:  West J Med       Date:  1985-10

7.  Add-On Selective Estrogen Receptor Modulators for Methadone Maintenance Treatment.

Authors:  Chieh-Liang Huang; Yao-Chang Chiang; Wei-Chun Chang; Yu-Ting Su; Juan-Cheng Yang; Wei-Chung Cheng; Hsien-Yuan Lane; Ing-Kang Ho; Wen-Lung Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-05       Impact factor: 5.555

8.  Sex- and Dose-Dependent Differences in the Development of an Addiction-Like Phenotype Following Extended-Access Fentanyl Self-Administration.

Authors:  Eleanor Blair Towers; Ben Setaro; Wendy J Lynch
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.988

9.  Establishing preclinical withdrawal syndrome symptomatology following heroin self-administration in male and female rats.

Authors:  Cassandra D Gipson; Kelly E Dunn; Amanda Bull; Hanaa Ulangkaya; Aronee Hossain
Journal:  Exp Clin Psychopharmacol       Date:  2020-04-16       Impact factor: 3.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.